The Center for Continuing Medical Education (CCME)
  1. Home
  2. Grand Rounds
  3. Neurology Grand Rounds
  4. Modulating IL-6/STAT3 Signaling for Multiple Sclerosis Therapy

Modulating IL-6/STAT3 Signaling for Multiple Sclerosis Therapy

Neurology Grand Rounds

Tuesday, September 27, 2016 at 7:30 AM

This grand round has already taken place.

170 Davis Heart and Lung - Columbus, OH
September 27th, 2016
1.00 AMA PRA Category 1 Credit™ Hours

Dates and Times

Start: 9/27/2016 7:30 AM
End: 9/27/2016 7:30 AM

Objectives

1. Discuss the topic presented and how it's relevant to patient care.
2. Idenity areas of new research in the area
3. Modify the management of patients based on their initial presentation

Speakers

  • Dr. Yuhong Yang, MD
    • Modulating IL-6/STAT3 Signaling for Multiple Sclerosis Therapy

Location

170 Davis Heart and Lung
473 W. 12th Avenue
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.